NCT07409376

Brief Summary

This study is designed as a controlled trial to evaluate the efficacy of balloon-assisted enteroscopy-guided radial incision therapy for the treatment of stricturing small bowel Crohn's disease. The study aims to compare therapeutic outcomes, procedure-related complications, and recurrence rates in patients with stricturing small bowel Crohn's disease undergoing balloon-assisted enteroscopy-guided radial incision therapy. The results are expected to provide a novel and reliable treatment option for patients with stricturing Crohn's disease and to lay a foundation for improving disease-related symptoms and quality of life.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
31mo left

Started Mar 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Mar 2026Dec 2028

First Submitted

Initial submission to the registry

February 9, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 13, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

February 13, 2026

Status Verified

December 1, 2025

Enrollment Period

1.8 years

First QC Date

February 9, 2026

Last Update Submit

February 12, 2026

Conditions

Keywords

Crohn's Disease; balloon-assisted enteroscopy; stricture

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients not requiring additional therapeutic interventions at 1-year follow-up

    Percentage of patients who do not require any new therapeutic intervention, including endoscopic balloon dilation (EBD), endoscopic stricture incision (EST), or surgery, within 1 year after the initial procedure.

    1 year

Secondary Outcomes (6)

  • Proportion of patients not requiring additional therapeutic interventions at 3-year follow-up

    3 years

  • Proportion of patients not requiring additional therapeutic interventions at 5-year follow-up

    5 years

  • Safety assessment of the two treatment methods

    Within 2 months post-procedure

  • Immediate technical success of the procedure

    At the time of procedure

  • Symptom-free duration within 1 year post-procedure

    1 year

  • +1 more secondary outcomes

Study Arms (3)

No Intervention

SHAM COMPARATOR

Patients in this arm will not receive endoscopic interventional treatment for small bowel strictures and will be managed with standard medical therapy and clinical observation.

Procedure: No Interventions

Balloon-assisted enteroscopy-guided balloon dilation

EXPERIMENTAL

Patients in this arm will undergo balloon dilation of small bowel strictures under balloon-assisted enteroscopy to relieve luminal narrowing.

Procedure: balloon dilation

Balloon-assisted enteroscopy-guided stricture incision

EXPERIMENTAL

Patients in this arm will receive balloon-assisted enteroscopy-guided radial incision of small bowel strictures under direct endoscopic visualization.

Procedure: stricture incision

Interventions

Balloon-assisted enteroscopy-guided stricture incision versus balloon dilation

Balloon-assisted enteroscopy-guided stricture incision

Balloon-assisted enteroscopy-guided balloon dilation

Balloon-assisted enteroscopy-guided balloon dilation

No Intervention

No Intervention

Eligibility Criteria

Age16 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 16 and 75 years.
  • Diagnosis of Crohn's disease with primary or secondary small bowel stricture confirmed by imaging studies, or small bowel stricture identified by enteroscopy.
  • Inadequate response to conventional medical therapy and step-up treatment strategies.
  • Stricture length less than 5 cm.
  • Signed informed consent form.

You may not qualify if:

  • Bowel wall thickening with Limberg grade IV blood flow on intestinal ultrasound, or presence of complications such as perforation, fistula, deep ulcer, inflammatory mass, or abscess.
  • Deep ulcer in the stricture segment observed by enteroscopy, potentially involving the muscular layer.
  • Presence of strictures in the esophagus, stomach, or duodenum.
  • Presence of colorectal stricture or ileocecal valve stricture.
  • Small bowel stricture complicated by abscess, fistula, or severe angulation.
  • Patients with ≥3 small bowel strictures or stricture length ≥5 cm.
  • Strictures previously treated with stent placement, dilation, or incision but without sustained symptom-free remission for at least 1 year.
  • Pregnancy or breastfeeding.
  • Inability to undergo endoscopic treatment.
  • Severe coagulation disorders (platelet count \<70,000/μL, INR \>1.5).
  • Concomitant advanced tumors or other severe organ diseases.
  • Suspected localized intestinal malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Crohn DiseaseConstriction, Pathologic

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Yan Chen, PhD

    Second Affiliated Hospital of Zhejiang University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shenglong Xia, Phd

CONTACT

Surong Hu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2026

First Posted

February 13, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

February 13, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share